# VICTOR - Avelox® Intravenous (i.v.) in Acute Exacerbations of Chronic Bronchitis

> **NCT00876577** · — · COMPLETED · sponsor: **Bayer** · enrollment: 1206 (actual)

## Conditions studied

- Chronic Bronchitis
- Disease Exacerbation

## Interventions

- **DRUG:** Moxifloxacin (Avelox, BAY12-8039)

## Key facts

- **NCT ID:** NCT00876577
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 1206 (ACTUAL)
- **Last updated:** 2012-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00876577

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00876577, "VICTOR - Avelox® Intravenous (i.v.) in Acute Exacerbations of Chronic Bronchitis". Retrieved via AI Analytics 2026-08-23 from https://api.ai-analytics.org/clinical/NCT00876577. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*